Bayer Aktiengesellschaft (BAYZF)
- Previous Close
28.99 - Open
29.08 - Bid --
- Ask --
- Day's Range
29.08 - 29.08 - 52 Week Range
27.41 - 65.91 - Volume
220 - Avg. Volume
34,363 - Market Cap (intraday)
28.877B - Beta (5Y Monthly) 0.97
- PE Ratio (TTM)
-- - EPS (TTM)
-3.20 - Earnings Date --
- Forward Dividend & Yield 0.12 (0.41%)
- Ex-Dividend Date Apr 29, 2024
- 1y Target Est
--
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health. The Crop Science segment offers seeds, improved plant traits, innovative chemical and biological crop protection products, digital solutions, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration with Acuitas Therapeutics, Inc. to strengthen gene editing programs; Peking University in the area of basic pharmaceutical research; the Swiss Tropical and Public Health Institute in the development of the compound emodepside for the treatment of infection with soil-transmitted helminths; bit.bio Ltd. for the discovery and manufacture of regulatory T cells for use in creating therapeutics; Hologic, Inc. in the field of contrastenhanced-mammography solutions to improve diagnostic imaging for the detection of breast cancer; and Twist Bioscience Corporation centering around the research and development of antibody-based pharmaceuticals, as well as with CrossBay Medical Inc. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company has collaboration with Thermo Fisher Scientific. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
www.bayer.com96,931
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: BAYZF
Performance Overview: BAYZF
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BAYZF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BAYZF
Valuation Measures
Market Cap
28.88B
Enterprise Value
63.51B
Trailing P/E
--
Forward P/E
5.21
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.56
Price/Book (mrq)
0.81
Enterprise Value/Revenue
1.33
Enterprise Value/EBITDA
6.08
Financial Highlights
Profitability and Income Statement
Profit Margin
-6.17%
Return on Assets (ttm)
4.04%
Return on Equity (ttm)
-8.17%
Revenue (ttm)
47.64B
Net Income Avi to Common (ttm)
-2.94B
Diluted EPS (ttm)
-3.20
Balance Sheet and Cash Flow
Total Cash (mrq)
10.59B
Total Debt/Equity (mrq)
136.06%
Levered Free Cash Flow (ttm)
1.52B
Company Insights: BAYZF
BAYZF does not have Company Insights
Research Reports: BAYZF
Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover
In this edition, the United Auto Workers are likely to hit the brakes; interest in green hydrogen is rising; oil prices are falling, and gas prices aren't, and Nike, Bayer, and Sanofi.
Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover
In this edition, global oil inventories face future; feeling the internet's backbone; and initiating coverage of Qualys; and Lithium Americas, Bausch & Lomb and Macy's.
Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover
In this edition, railroads may be in for a bumpy ride; ESG has some opportunities; biotechs innovate; and Constellation Brands, Autodesk, and Tencent.
Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover
In this edition, railroads may be in for a bumpy ride; ESG has some opportunities; biotechs innovate; and Constellation Brands, Autodesk, and Tencent.